IL2 and myeloid sarcoma: We found that in RR-MS patients, the presence of the T-allele was associated with reduced expression of IL-5 and of IL-1ra, and with higher levels of several proinflammatory cytokines, including IL-2, IL-6, IL-15, and GM-CSF.